Drug & Device Safety Atlas
Class II FDA drug recall · D-0350-2026

Class II — the FDA judged the product may cause temporary or medically reversible harm, with a remote chance of serious harm.

This is the FDA's risk judgment for this recall. It describes the potential of the product as a category — it does not establish that any specific unit harmed anyone. Most recalls are Class II or III.

CHNaO Fluorescein Sodium Ophthalmic Strips, USP 1mg, packaged as a) 100-count box, NDC 83851-100-10; b) 300-count box, NDC 83851-100-30. Manufactured by Wizcure Pharmaa PVT. LTD, H-681, Phase 3, RIICO Industrial Area, Bhiwadi- 301019 INDIA, Vistamerica USA, 20 Perkins Dr. Prescott, AZ 86301, Vistamerica USA, Made in India,

Why it was recalled

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

The recall was initiated by Wizcure Pharmaa Private Limited (the firm that distributes or relabels it); the product is made by Vistamerica USA. That is normal — the distributor, not always the maker, files the recall.

Is your unit affected?

The recall covers only the specific lots or serial numbers the FDA listed. Enter the lot or serial number from your product's label and we'll check it against that list.

A match means your unit may be covered — stop and call your pharmacist before doing anything. No match suggests it isn't covered, but confirm anyway: code formats vary and lists can be incomplete. Your unit not being listed does not guarantee it is safe, and being listed does not mean you have been harmed.

Show the FDA's listed lot / code information
All lots

Recall status

Ongoing — the recall is still being carried out.

Where it was distributed

Distributed Nationwide in the USA

Recall record

Recalling firm
Wizcure Pharmaa Private Limited
Manufacturer
Vistamerica USA
Brand name
C20H10NA2O5 FLUORESCEIN SODIUM OPHTHALMIC STRIPS
Generic name
FLUORESCEIN SODIUM
Product type
Drugs
Recall number
D-0350-2026
Voluntary / mandated
Voluntary: Firm initiated
Initial notification
Letter
Origin
Bhiwadi, N/A
Recall initiated
2025-12-31

What to do

Check the lot/code above against your product. To confirm this record and read the FDA's full notice, see the FDA recall page. Before changing anything you take or use, ask your pharmacist or prescriber — this page does not tell you to start or stop any drug or device.

Also available: structured data (JSON-LD) · recall record (JSON)

What this is — and is not

A recall is a recorded FDA enforcement action — the FDA logged that a firm is removing or correcting a product. It does not establish that any specific unit harmed anyone, and causation is not established by a recall. The class above is the FDA's risk judgment for the product category, not a finding about your unit. This page informs and compares; it is not medical advice and never tells you to start or stop a drug or device.

To report a problem you experienced, use FDA MedWatch. Verify this record at FDA recalls · Recall D-0350-2026 · Source: openFDA enforcement.